PBU The Pension Fund of Early Childhood & Youth Educators acquired a new stake in shares of Kenvue Inc. (NYSE:KVUE – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 527,871 shares of the company’s stock, valued at approximately $9,106,000.
Several other institutional investors and hedge funds have also recently made changes to their positions in KVUE. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Kenvue during the 2nd quarter valued at $6,528,000. Jump Financial LLC raised its position in shares of Kenvue by 210.6% during the 2nd quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock valued at $1,147,000 after buying an additional 37,170 shares in the last quarter. AXA S.A. raised its position in shares of Kenvue by 21.1% during the 2nd quarter. AXA S.A. now owns 48,892 shares of the company’s stock valued at $1,023,000 after buying an additional 8,524 shares in the last quarter. NewEdge Advisors LLC raised its position in shares of Kenvue by 219.1% during the 2nd quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock valued at $2,040,000 after buying an additional 66,930 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its position in shares of Kenvue by 0.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock valued at $39,217,000 after buying an additional 10,885 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the stock. Weiss Ratings lowered shares of Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 29th. Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Argus raised shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Citigroup reduced their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Finally, Barclays reduced their target price on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $19.33.
Insider Transactions at Kenvue
In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.59% of the stock is currently owned by company insiders.
Kenvue Price Performance
KVUE stock opened at $17.72 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $22.87. The firm’s fifty day moving average is $17.37 and its 200 day moving average is $17.48. The firm has a market cap of $34.01 billion, a P/E ratio of 20.84, a P/E/G ratio of 1.34 and a beta of 0.54.
Kenvue (NYSE:KVUE – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same quarter last year, the firm earned $0.24 EPS. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. Research analysts predict that Kenvue Inc. will post 1.16 earnings per share for the current year.
Kenvue Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were issued a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is 97.65%.
Kenvue Profile
Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.
The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.
Featured Articles
- Five stocks we like better than Kenvue
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE – Free Report).
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.
